LORATAN A 50 (Losartan (50mg) + Amlodipine (5mg))
-58%

LORATAN A 50 (Losartan (50mg) + Amlodipine (5mg))

Original price was: ₹118.10.Current price is: ₹50.00.

Placeholder

Original price was: ₹118.10.Current price is: ₹50.00.

Add to cart
Buy Now
Category: Tag:

Loratana A is a medication available in the form of tablets, indicated for the management of specific conditions related to allergies and other similar health issues. The active ingredient has antiallergic properties, providing relief from symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes. This medication works by blocking certain natural substances in the body, thus helping to alleviate discomfort associated with allergic reactions. It is essential to follow the prescribed dosage and administration guidelines to ensure effectiveness and reduce the risk of adverse effects. When starting this medication, some individuals may experience initial discomfort or side effects as their bodies adjust to the treatment. It is advisable to consult a healthcare professional for any questions regarding the medication or if any concerns arise during treatment. A thorough discussion with a medical provider can help determine if this medication is suitable based on an individual’s health status and medical history. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “LORATAN A 50 (Losartan (50mg) + Amlodipine (5mg))”

Your email address will not be published. Required fields are marked *

Top